DMC Best Practices: What Biotechs and Sponsors Should Know  

1 minute read

Published: August 5th, 2025

Data Monitoring Committees (DMC) are a critical part of the clinical trial process, independently assessing the safety of an investigational product and at times the futility/efficacy. Successfully navigating DMC set-up, logistics, and independent data review can be complex, especially for biotech and smaller sponsors without in-house expertise. 

Speakers:
  • Lucy Clark, Statistics Manager
  • Lisa Gibbons, Senior Statistician
  • Matt George (Moderator), Senior Statistician
Learning Points :
  • Share best practices for establishing and running an effective Data Monitoring Committee
  • Explore the critical role of an Independent Data Analysis Centre (IDAC) in ensuring compliant, high-quality DMC operations.
  • Present real-world case studies showcasing successful DMC implementation in high-stakes clinical trials.
Complete the form below to access the recording and slides:

Related articles

Bridging the Efficacy-Effectiveness Gap in Rare Diseases

Bridging the Efficacy-Effectiveness Gap in Rare Diseases

June 18th, 2026 1 minute read

Drug development in rare diseases requires the most efficient use of limited data, across both clinical trials and re...

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

June 9th, 2026 1 minute read

About This Webinar Bayesian methods continue to gain momentum as an alternative approach to traditional clinical tria...

Identifying the Best Populations to Target, De-Risking Discovery and Early-Stage Development

Identifying the Best Populations to Target, De-Risking Discovery and Early-Stage Development

June 3rd, 2026 1 minute read

About This Webinar In this session, we explore real-world use cases where AI and LLMs (Large Language Models) have be...